On March 6, 2015 the U.S. FDA approved Sandoz’s Zarxio (filgrastim), the..
As of 12/03/2018 our Disruptive Technology portfolio has has a 21% return so..
The Macrovue Social Media thematic portfolio, known as a ‘Vue’, has..
This article was featured on The Australian on 21st April, written by..
The Feed the World Vue is a portfolio that includes companies which have..
The Luxury Goods Vue is a concentrated share portfolio of high conviction..